Microbot Stock Based Compensation vs Capital Expenditures Analysis

MBOT Stock

USD 0.97 0.00 0.000003%

Microbot Medical financial indicator trend analysis is infinitely more than just investigating Microbot Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbot Medical is a good investment. Please check the relationship between Microbot Medical Stock Based Compensation and its Capital Expenditures accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.

Stock Based Compensation vs Capital Expenditures

Stock Based Compensation vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbot Medical Stock Based Compensation account and Capital Expenditures. At this time, the significance of the direction appears to have no relationship.

The correlation between Microbot Medical's Stock Based Compensation and Capital Expenditures is 0.03. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Microbot Medical, assuming nothing else is changed. The correlation between historical values of Microbot Medical's Stock Based Compensation and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Microbot Medical are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Stock Based Compensation i.e., Microbot Medical's Stock Based Compensation and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.03

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Capital Expenditures

Capital Expenditures are funds used by Microbot Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Microbot Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Microbot Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbot Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbot Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Microbot Stock please use our How to Invest in Microbot Medical guide.At this time, Microbot Medical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 28.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.9 M in 2024.

Microbot Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock	Short Term Investments	Current Deferred Revenue
Total Assets		0.56	0.34	0.58	0.63	0.67	-0.73	-0.6	0.01	0.9	0.73	0.53	0.97	-0.1	-0.43	0.7	0.44	0.64	0.69	0.97	0.58	0.34	0.36	0.34	0.01	-0.21
Short Long Term Debt Total	0.56		0.72	0.86	-0.17	0.94	-0.07	-0.75	-0.04	0.6	0.68	0.09	0.45	-0.01	-0.46	0.83	0.01	0.75	0.87	0.46	0.95	0.51	0.46	0.45	-0.4	-0.27
Other Current Liab	0.34	0.72		0.9	-0.46	0.77	0.3	-0.89	0.35	0.15	0.73	0.39	0.15	0.13	-0.39	0.8	-0.11	0.88	0.86	0.17	0.61	0.3	0.63	0.64	-0.22	-0.47
Total Current Liabilities	0.58	0.86	0.9		-0.2	0.87	0.0	-0.87	0.28	0.47	0.75	0.4	0.42	0.16	-0.38	0.84	0.21	0.86	0.93	0.45	0.79	0.38	0.56	0.56	-0.31	-0.42
Total Stockholder Equity	0.63	-0.17	-0.46	-0.2		-0.06	-0.92	0.19	-0.18	0.66	0.03	0.23	0.77	-0.16	0.04	-0.09	0.55	-0.14	-0.12	0.76	-0.09	0.01	-0.22	-0.24	0.25	0.15
Property Plant And Equipment Net	0.67	0.94	0.77	0.87	-0.06		-0.14	-0.85	0.13	0.63	0.82	0.33	0.54	-0.05	-0.55	0.89	0.03	0.86	0.92	0.54	0.86	0.63	0.62	0.61	-0.23	-0.22
Net Debt	-0.73	-0.07	0.3	0.0	-0.92	-0.14		-0.06	0.02	-0.84	-0.19	-0.33	-0.83	0.25	0.18	-0.09	-0.56	0.01	-0.07	-0.82	-0.13	-0.13	0.02	0.05	-0.04	-0.16
Retained Earnings	-0.6	-0.75	-0.89	-0.87	0.19	-0.85	-0.06		-0.25	-0.36	-0.91	-0.55	-0.42	-0.03	0.54	-0.95	0.06	-1.0	-0.96	-0.43	-0.67	-0.36	-0.76	-0.76	0.14	0.49
Accounts Payable	0.01	-0.04	0.35	0.28	-0.18	0.13	0.02	-0.25		-0.04	0.34	0.65	-0.1	0.11	-0.19	0.13	-0.05	0.24	0.19	-0.09	-0.08	0.2	0.56	0.58	0.05	0.05
Cash	0.9	0.6	0.15	0.47	0.66	0.63	-0.84	-0.36	-0.04		0.52	0.32	0.92	-0.19	-0.39	0.53	0.46	0.4	0.53	0.92	0.62	0.39	0.24	0.2	-0.18	-0.02
Non Current Assets Total	0.73	0.68	0.73	0.75	0.03	0.82	-0.19	-0.91	0.34	0.52		0.66	0.57	-0.03	-0.64	0.94	-0.03	0.92	0.91	0.56	0.64	0.47	0.76	0.75	-0.03	-0.3
Non Currrent Assets Other	0.53	0.09	0.39	0.4	0.23	0.33	-0.33	-0.55	0.65	0.32	0.66		0.41	-0.23	-0.55	0.47	0.3	0.56	0.47	0.43	0.03	0.2	0.75	0.74	0.13	-0.11
Cash And Short Term Investments	0.97	0.45	0.15	0.42	0.77	0.54	-0.83	-0.42	-0.1	0.92	0.57	0.41		-0.13	-0.32	0.55	0.48	0.47	0.53	0.99	0.51	0.27	0.18	0.16	0.04	-0.14
Net Receivables	-0.1	-0.01	0.13	0.16	-0.16	-0.05	0.25	-0.03	0.11	-0.19	-0.03	-0.23	-0.13		0.61	-0.02	0.06	0.02	0.02	-0.11	0.08	-0.07	-0.22	-0.16	0.02	-0.21
Common Stock Shares Outstanding	-0.43	-0.46	-0.39	-0.38	0.04	-0.55	0.18	0.54	-0.19	-0.39	-0.64	-0.55	-0.32	0.61		-0.64	0.1	-0.54	-0.59	-0.3	-0.4	-0.51	-0.66	-0.6	-0.07	-0.2
Non Current Liabilities Total	0.7	0.83	0.8	0.84	-0.09	0.89	-0.09	-0.95	0.13	0.53	0.94	0.47	0.55	-0.02	-0.64		-0.03	0.96	0.98	0.54	0.8	0.43	0.69	0.67	-0.16	-0.39
Other Current Assets	0.44	0.01	-0.11	0.21	0.55	0.03	-0.56	0.06	-0.05	0.46	-0.03	0.3	0.48	0.06	0.1	-0.03		-0.03	0.05	0.55	0.02	-0.09	-0.13	-0.14	-0.14	-0.04
Other Stockholder Equity	0.64	0.75	0.88	0.86	-0.14	0.86	0.01	-1.0	0.24	0.4	0.92	0.56	0.47	0.02	-0.54	0.96	-0.03		0.96	0.48	0.68	0.36	0.76	0.76	-0.13	-0.48
Total Liab	0.69	0.87	0.86	0.93	-0.12	0.92	-0.07	-0.96	0.19	0.53	0.91	0.47	0.53	0.02	-0.59	0.98	0.05	0.96		0.54	0.83	0.43	0.67	0.66	-0.22	-0.41
Total Current Assets	0.97	0.46	0.17	0.45	0.76	0.54	-0.82	-0.43	-0.09	0.92	0.56	0.43	0.99	-0.11	-0.3	0.54	0.55	0.48	0.54		0.49	0.26	0.19	0.16	0.02	-0.15
Short Term Debt	0.58	0.95	0.61	0.79	-0.09	0.86	-0.13	-0.67	-0.08	0.62	0.64	0.03	0.51	0.08	-0.4	0.8	0.02	0.68	0.83	0.49		0.48	0.35	0.34	-0.34	-0.25
Property Plant And Equipment Gross	0.34	0.51	0.3	0.38	0.01	0.63	-0.13	-0.36	0.2	0.39	0.47	0.2	0.27	-0.07	-0.51	0.43	-0.09	0.36	0.43	0.26	0.48		0.31	0.29	0.38	0.58
Common Stock Total Equity	0.36	0.46	0.63	0.56	-0.22	0.62	0.02	-0.76	0.56	0.24	0.76	0.75	0.18	-0.22	-0.66	0.69	-0.13	0.76	0.67	0.19	0.35	0.31		1.0	-0.23	-0.25
Common Stock	0.34	0.45	0.64	0.56	-0.24	0.61	0.05	-0.76	0.58	0.2	0.75	0.74	0.16	-0.16	-0.6	0.67	-0.14	0.76	0.66	0.16	0.34	0.29	1.0		-0.24	-0.29
Short Term Investments	0.01	-0.4	-0.22	-0.31	0.25	-0.23	-0.04	0.14	0.05	-0.18	-0.03	0.13	0.04	0.02	-0.07	-0.16	-0.14	-0.13	-0.22	0.02	-0.34	0.38	-0.23	-0.24		0.58
Current Deferred Revenue	-0.21	-0.27	-0.47	-0.42	0.15	-0.22	-0.16	0.49	0.05	-0.02	-0.3	-0.11	-0.14	-0.21	-0.2	-0.39	-0.04	-0.48	-0.41	-0.15	-0.25	0.58	-0.25	-0.29	0.58

Click cells to compare fundamentals

Microbot Medical Account Relationship Matchups

Microbot Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	37.1M	26.3M	16.8M	9.5M	8.3M	7.9M
Other Current Liab	608K	696K	1.4M	1.7M	3.2M	2.6M
Total Current Liabilities	4.8M	1.3M	2.0M	2.1M	3.8M	4.8M
Total Stockholder Equity	31.5M	24.3M	14.4M	7.3M	4.5M	4.3M
Property Plant And Equipment Net	1.2M	1.0M	888K	723K	406K	385.7K
Net Debt	(27.9M)	(18.8M)	(12.8M)	(2.0M)	(2.2M)	(2.3M)
Retained Earnings	(35.1M)	(44.3M)	(55.6M)	(68.8M)	(79.5M)	(83.5M)
Accounts Payable	284K	275K	279K	116K	357K	489.2K
Cash	28.8M	19.7M	13.5M	2.4M	2.5M	2.3M
Non Current Assets Total	1.2M	1.0M	888K	723K	406K	385.7K
Non Currrent Assets Other	259K	962K	5.0K	(1.0)	(0.9)	(0.85)
Cash And Short Term Investments	31.3M	24.6M	15.5M	8.2M	6.4M	6.1M
Net Receivables	101K	340K	174K	103K	1.3M	1.4M
Common Stock Shares Outstanding	4.3M	7.1M	7.1M	7.3M	10.2M	10.7M
Liabilities And Stockholders Equity	37.1M	26.3M	16.8M	9.5M	8.3M	7.9M
Non Current Liabilities Total	760K	626K	402K	179K	40K	38K
Other Current Assets	7.2M	265K	213K	609K	1.5M	1.5M
Other Stockholder Equity	66.6M	68.5M	69.9M	76.0M	83.9M	88.1M
Total Liab	5.6M	2.0M	2.4M	2.2M	3.8M	3.6M
Total Current Assets	35.9M	25.3M	15.9M	8.8M	7.9M	7.5M
Property Plant And Equipment Gross	1.2M	251.0	1.2M	1.1M	899K	854.1K
Common Stock Total Equity	406K	31K	72K	72.0	64.8	61.56
Common Stock	406K	31K	72K	80K	118K	112.1K
Net Tangible Assets	31.5M	24.3M	14.4M	7.3M	8.4M	11.1M
Retained Earnings Total Equity	(20.6M)	(27.9M)	(35.1M)	(44.3M)	(50.9M)	(53.5M)
Capital Surpluse	30.2M	32.5M	70.0M	68.5M	61.7M	58.6M
Property Plant Equipment	228K	1.0M	888K	723K	650.7K	1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microbot Stock Analysis

When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC